Breakpoints: current practice and future perspectives
- 1 April 2002
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 19 (4) , 323-331
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- History and development of antimicrobial susceptibility testing methodologyJournal of Antimicrobial Chemotherapy, 2001
- Determination of minimum inhibitory concentrationsJournal of Antimicrobial Chemotherapy, 2001
- Establishing MIC breakpoints and the interpretation of in vitro susceptibility testsJournal of Antimicrobial Chemotherapy, 2001
- Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemiaInternational Journal of Antimicrobial Agents, 1999
- Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumoniaJournal of Antimicrobial Chemotherapy, 1999
- Pharmacodynamics of Trovafloxacin, Ofloxacin, and Ciprofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic ModelAntimicrobial Agents and Chemotherapy, 1999
- Comparison of Efficacies of Oral Levofloxacin and Oral Ciprofloxacin in a Rabbit Model of a Staphylococcal AbscessAntimicrobial Agents and Chemotherapy, 1999
- Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of InfectionAntimicrobial Agents and Chemotherapy, 1999
- Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 1999
- A comparison of the activities antiseptics on bacteria and on leucocytesProceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1924